Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Bafna Pharmaceuticals Limited ( (IN:BAFNAPH) ) is now available.
Bafna Pharmaceuticals has announced the closure of its trading window for designated persons and their immediate relatives from April 1, 2026, until 48 hours after the declaration of audited financial results for the quarter and financial year ending March 31, 2026. The move, made in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code of conduct, reinforces its adherence to insider trading norms and aims to protect market integrity ahead of the forthcoming results disclosure.
More about Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited is an India-based pharmaceutical company headquartered in Chennai, Tamil Nadu. The company operates in the pharmaceuticals industry, manufacturing and marketing medicinal products and related formulations for domestic and potentially regulated markets, with its primary production facilities located in Chennai.
Average Trading Volume: 443
Technical Sentiment Signal: Buy
Current Market Cap: 2.8B INR
For detailed information about BAFNAPH stock, go to TipRanks’ Stock Analysis page.